Gangliosidosis (GM1)

General description

The gangliosidoses are progressive, fatal neurological diseases of cats where gangliosides accumulate principally in neuronal lysosomes. Affected kittens have head tremors at the beginning followed by impaired co-ordination of leg movements which eventually lead to paralysis.

Breeds

Balinese, Javanese, Korat, Oriental Shorthair (OSH), Peterbald, Seychellois, Siamese, Thai, Tonkinese

Order details
Test number8041
AbbreviationGM1
Sample material0.5 ml EDTA blood, 2x cheek swab, 1x special swab (eNAT)
Test duration7-14 working days
Test specifications
Symptom complexneurological
Inheritanceautosomal recessive
Age of onset2 months
Causalitycausally
GeneGLB1
MutationC-G
LiteratureOMIA:000402-9685
Detailed description

GM1 and GM2 belong to a group of inherited diseases known as “lysosomal storage diseases”. They are characterised by the accumulation of unprocessed material in enlarged lysosomes. The gangliosidoses are progressive, fatal neurological diseases of cats, humans and other animals where gangliosides accumulate principally in neuronal lysosomes. There are two types of gangliosidoses, GM1 and GM2 gangliosidosis. Affected kittens have head tremors at the beginning followed by impaired co-ordination of leg movements which eventually lead to paralysis. Although both types of gangliosidoses cause fatal progressive brain disease, they are caused by entirely different genetic errors of two different lysosomal enzymes. GM1 gangliosidosis is due to an inherited deficiency of the enzyme beta-galactosidase, whereas GM2 gangliosidosis is caused by a lack of the enzyme beta-hexosaminidase.


Ihr Experte für Tiergenetik!

Yhteydenottopyyntö

LABOGEN on osa
LABOKLIN GMBH CO.KG
Kliinisen diagnostiikan laboratoriota

… jossa kokemus ja laatu kohtaavat!

Copyright © 2024 LABOGEN by LABOKLIN. All Rights Reserved.